SAT-008 Overcoming BCL-2 Resistance in Glucocorticoid-Treated Tumor Lymphoid Cells
نویسندگان
چکیده
منابع مشابه
LYMPHOID NEOPLASIA Bcl-2, Bcl-xL, and Bcl-w are not equivalent targets of ABT-737 and navitoclax (ABT-263) in lymphoid and leukemic cells
1The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia; 2Department of Medical Biology, University of Melbourne, Melbourne, Australia; 3Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, Australia; 4Children’s Cancer Centre, Monash Medical Centre, Clayton, Australia; 5Department of Research Oncology, Genentech, South San Francisco...
متن کاملLYMPHOID NEOPLASIA Leukemia-initiating cells in human T-lymphoblastic leukemia exhibit glucocorticoid resistance
T-cell acute lymphoblastic leukemia (TALL) is associated with a significant risk of disease relapse, but the biological basis for relapse is poorly understood. Here, we identify leukemiainitiating cells (L-ICs) on the basis of functional assays and prospective isolation and report a role for L-ICs in T-ALL disease and relapse. Long-term proliferation in response to NOTCH1 activating signals in ...
متن کاملBcl-2–Mediated Drug Resistance
Bcl-2 inhibits apoptosis induced by a variety of stimuli, including chemotherapy drugs and glucocorticoids. It is generally accepted that Bcl-2 exerts its antiapoptotic effects mainly by dimerizing with proapoptotic members of the Bcl-2 family such as Bax and Bad. However, the mechanism of the antiapoptotic effects is unclear. Paclitaxel and other drugs that disturb microtubule dynamics kill ce...
متن کاملOvercoming Multidrug Resistance in Cancer Stem Cells
The principle mechanism of protection of stem cells is through the expression of ATP-binding cassette (ABC) transporters. These transporters serve as the guardians of the stem cell population in the body. Unfortunately these very same ABC efflux pumps afford protection to cancer stem cells in tumors, shielding them from the adverse effects of chemotherapy. A number of strategies to circumvent t...
متن کاملAlendronate-Related Femoral Fracture in a premenopausal glucocorticoid treated patient
Abstract Background: Alendronate is a bisphosphonate that is approved to reduce bone loss in glucocorticoid treated patients. In this paper, we present a case of femoral fracture following the use of Alendronate. Case presentation: A- 46 year old woman who was a known case of hemolytic anemia has been treated by prednisolone (with different doses from 7.5 to 75 mg/day), calcium-D 500 mg/day a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the Endocrine Society
سال: 2019
ISSN: 2472-1972
DOI: 10.1210/js.2019-sat-008